Robin Wenzel, head of Wells Fargo Industry Insights, said that the rise of GLP-1s has brought down the rate of bariatric surgery by more than 30%, providing a less invasive 'pharmaceutical offramp' for weight management. Wenzel said GLP-1 use rose 120% between 2022 and 2024 and that it offers the parts of the healthcare industry an opportunity to turn to helping patients manage medication or their side effects. (Source: Bloomberg)
Business
5 views
Wells Fargo Report Says GLP-1s Reducing Certain Surgeries
Robin Wenzel, head of Wells Fargo Industry Insights, said that the rise of GLP-1s has brought down the rate of bariatric surgery by more than 30%, providing a less invasive 'pharmaceutical offramp' for weight…
Business
Robin Wenzel, head of Wells Fargo Industry Insights, said that the rise of GLP-1s has brought down the rate of bariatric surgery by more than 30%, providing a less invasive 'pharmaceutical.
Bloomberg Verified Source
Syndicated via official news feed
Explore all Business stories
Syndicated feed content with full publisher credit.
Business Desk
More in Business
Continue reading verified coverage and related developments on this desk.
More from Business
Latest developments and reports from the desk
BUSINESS
Carne de Brasil enfrenta nuevas restricciones de Unión Europea
Nuevas exigencias de trazabilidad amenazan las exportaciones brasileñas de carne vacuna a Europa y ponen en riesgo un mercado de precios más altos. Nuevas exigencias de trazabilidad amenazan las exportaciones…
BUSINESS
Yen Surges With Traders on High Alert for Further Intervention
The yen strengthened sharply against the US currency, leaving traders on high alert for the potential that authorities may once again intervene in the foreign-exchange market.
BUSINESS
Faisal Islam: Why bond market wildfire is keeping world leaders up at night
Huge AI spending plans and the ongoing war in Iran are driving up borrowing costs around the world.